Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773 | Synapse
March 15, 2026Open Access
Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773
Puntos clave
To correct previous findings regarding the prognostic value of HSP27 and menin in prostate cancer.
Data correction in the published study on biomarkers.
Re-evaluation of HSP27 and menin expression levels in prostate cancer samples.
Assessment of biomarkers' relationship with prostate cancer aggressiveness and PSA levels.
HSP27 is confirmed as a prognostic biomarker in prostate cancer.
Menin's role is clarified in the context of prostate cancer aggressiveness.
The independence of HSP27 and PSA levels reaffirms their significance as biomarkers.
Resumen
There was an oversight in the original publication ...